STAAR Surgical
STAA
185 hedge funds and large institutions have $922M invested in STAAR Surgical in 2025 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 70 increasing their positions, 58 reducing their positions, and 54 closing their positions.
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
21% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 58
7.73% more ownership
Funds ownership: 98.2% → 105.93% (+7.7%)
13% less funds holding
Funds holding: 212 → 185 (-27)
22% less capital invested
Capital invested by funds: $1.18B → $922M (-$254M)
45% less call options, than puts
Call options by funds: $2.76M | Put options by funds: $5M
50% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 54
Top Buyers
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$51.4M |
| 2 |
AC
Armistice Capital
New York
|
+$42.7M |
| 3 |
BC
Broadwood Capital
New York
|
+$32.2M |
| 4 |
YC
Yunqi Capital
Hong Kong
|
+$23.5M |
| 5 |
RAM
Resona Asset Management
Koto-Ku,tokyo,
Japan
|
+$13.4M |
Top Sellers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$28M |
| 2 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
-$16.1M |
| 3 |
Millennium Management
New York
|
-$11.7M |
| 4 |
BlackRock
New York
|
-$9.52M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.82M |
STAA Hedge Fund Activity: Q1 2025 in Review
185 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q1 2025, worth a combined $922M — down 22% from $1.18B a quarter earlier.
Sellers outnumbered buyers: 54 funds closed out of STAA and 27 opened new positions — a net loss of 27 holders — while 58 trimmed existing stakes and 70 added.
The largest buyer was Soleus Capital Management, opening a new position worth an estimated $51.4M. The largest seller was Baillie Gifford & Co, exiting entirely with an estimated $28M sold.
- 185 institutional investors held STAAR Surgical (STAA) as of Q1 2025, down from 212 in Q4 2024.
- Funds reported $922M of STAAR Surgical stock for Q1 2025, down 22% quarter-over-quarter.
- 27 funds opened new STAAR Surgical positions in Q1 2025 and 54 closed out, a net change of -27 holders.
- The largest STAAR Surgical buyer in Q1 2025 was Soleus Capital Management, an estimated $51.4M added.
- The largest STAAR Surgical seller in Q1 2025 was Baillie Gifford & Co, an estimated $28M sold.
Based on aggregated 13F filings for Q1 2025.